E. Dapretto

605 total citations
6 papers, 471 citations indexed

About

E. Dapretto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, E. Dapretto has authored 6 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in E. Dapretto's work include Pancreatic and Hepatic Oncology Research (2 papers), Hormonal and reproductive studies (2 papers) and Gastric Cancer Management and Outcomes (2 papers). E. Dapretto is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Hormonal and reproductive studies (2 papers) and Gastric Cancer Management and Outcomes (2 papers). E. Dapretto collaborates with scholars based in Italy. E. Dapretto's co-authors include Roberto Labianca, Francesco Di Costanzo, Massimo Di Maïo, Francesco Perrone, Sandro Barni, Vittorio Gebbia, Alberto Zaniboni, Evaristo Maiello, B. Massidda and Francesco Giuliani and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

E. Dapretto

6 papers receiving 457 citations

Peers

E. Dapretto

ONCOL

CR

PRM

EPIDE

SURGE

Kensuke Nakazawa Japan

A. Michelotti Italy

Mutsumi Fukunaga Japan

Francesco Puleo Belgium

William Schmidt United States

Αναστάσιος Γκουντάκος Italy

Manfred Kindler Germany

M Paesmans Belgium

De-Chuan Chan Taiwan

Kensuke Nakazawa Japan

E. Dapretto

279 ×0.7

ONCOL

67 ×0.5

CR

273 ×2.1

PRM

89 ×0.9

EPIDE

57 ×0.8

SURGE

Citations per year, relative to E. Dapretto E. Dapretto (= 1×) peers Kensuke Nakazawa

Countries citing papers authored by E. Dapretto

Since Specialization

Citations

This map shows the geographic impact of E. Dapretto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Dapretto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Dapretto more than expected).

Fields of papers citing papers by E. Dapretto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Dapretto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Dapretto. The network helps show where E. Dapretto may publish in the future.

Co-authorship network of co-authors of E. Dapretto

This figure shows the co-authorship network connecting the top 25 collaborators of E. Dapretto. A scholar is included among the top collaborators of E. Dapretto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Dapretto. E. Dapretto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Labianca, Roberto, Alberto F. Sobrero, L. Isa, et al.. (2010). Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised ‘GISCAD’ trial. Annals of Oncology. 22(5). 1236–1242. 72 indexed citations

2.

Colucci, Giuseppe, Roberto Labianca, Francesco Di Costanzo, et al.. (2010). Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study. Journal of Clinical Oncology. 28(10). 1645–1651. 240 indexed citations

3.

Cascinu, Stefano, Rossana Berardi, Roberto Labianca, et al.. (2008). Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial. The Lancet Oncology. 9(1). 39–44. 108 indexed citations

4.

Gardani, G, Monica Casiraghi, E. Dapretto, et al.. (2007). A progress study of 100 cancer patients treated by acupressure for chemotherapy-induced vomiting after failure with the pharmacological approach.. PubMed. 98(6). 665–8. 24 indexed citations

5.

Lissoni, Paolo, A. Bignami, L. Frontini, et al.. (2005). Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer. The International Journal of Biological Markers. 20(2). 123–125. 15 indexed citations

6.

Lissoni, Paolo, A. Bignami, L. Frontini, et al.. (2005). Possible Involvement of Prolactin in Endocrine-Resistant Metastatic Prostate Cancer. The International Journal of Biological Markers. 20(2). 123–125. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact